Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Amgen leads the 24 biotech companies ranked by cash on hand, at NOK 88.4B, ahead of BioNTech (NOK 82.4B) and Gilead Sciences (NOK 73.2B). Figures as of 18 Nov 2026, 22:14 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenNOK 88.4B
Median
NOK 4.2B
Combined market value
NOK 8.1T
Countries
5

Market values as of .

All countries
All sectors
Biotech
NOK
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareNOK 88.4BNOK 2.32TNOK 4,296.98 3.07% down 34% up United States
2BioNTechBNTX · Health CareNOK 82.4BNOK 199.8BNOK 805.98 1.89% down 16% down Germany
3Gilead SciencesGILD · Health CareNOK 73.2BNOK 2.03TNOK 1,635.77 0.75% down 33% up United States
4argenxARGX · Health CareNOK 33.8BNOK 573BNOK 9,111.55 0.66% down 4% up Belgium
5BiogenBIIB · Health CareNOK 29.1BNOK 359.8BNOK 2,433.72 0.25% up 49% up United States
6ModernaMRNA · Health CareNOK 25.1BNOK 770.8BNOK 1,904.98 4.84% down 755% up United States
7ImmunovantIMVT · Health CareNOK 8.7BNOK 66.4BNOK 321.09 0.12% down 43% up United States
8QiagenQGEN · Health CareNOK 8.1BNOK 99.1BNOK 479.75 0.38% down 12% up Netherlands
9Neurocrine BiosciencesNBIX · Health CareNOK 6.9BNOK 159.6BNOK 1,576.53 1.84% down 20% up United States
10RepligenRGEN · Health CareNOK 5.5BNOK 106.8BNOK 1,671.49 6.47% up 5% up United States
11Krystal BiotechKRYS · Health CareNOK 4.8BNOK 90.5BNOK 3,052.58 5.62% up 46% up United States
12ExelixisEXEL · Health CareNOK 4.7BNOK 161.3BNOK 661.07 0.31% down 63% up United States
13Revolution MedicinesRVMD · Health CareNOK 3.7BNOK 334.6BNOK 1,547.10 1.76% down 131% up United States
14Kymera TherapeuticsKYMR · Health CareNOK 3.5BNOK 100.1BNOK 1,172.57 0.32% down 87% up United States
15CRISPR TherapeuticsCRSP · Health CareNOK 3.4BNOK 37.7BNOK 389.05 0.10% up 21% down Switzerland
16Scholar Rock HoldingSRRK · Health CareNOK 3.1BNOK 56.7BNOK 464.65 6.48% up 14% up United States
17Bio-TechneTECH · Health CareNOK 2.6BNOK 110.6BNOK 704.24 0.17% up 26% up United States
18Kodiak SciencesKOD · Health CareNOK 2BNOK 61.9BNOK 946.83 1.04% up 396% up United States
19Twist BioscienceTWST · Health CareNOK 1.8BNOK 76.8BNOK 1,126.30 3.88% up 340% up United States
20VaxcytePCVX · Health CareNOK 1.7BNOK 89.7BNOK 566.49 1.48% down 22% up United States
21Halozyme TherapeuticsHALO · Health CareNOK 1.3BNOK 105.7BNOK 927.37 0.18% down 37% up United States
22ImmunityBioIBRX · Health CareNOK 855.1MNOK 69BNOK 64.86 7.03% up 193% up United States
23Adaptive BiotechnologiesADPT · Health CareNOK 682.4MNOK 44.6BNOK 275.50 0.11% down 88% up United States
24CG OncologyCGON · Health CareNOK 314.5MNOK 69.2BNOK 774.42 1.34% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6803 NOK).

Questions and answers

Which biotech companies rank first by cash on hand?

Amgen (NOK 88.4B), BioNTech (NOK 82.4B) and Gilead Sciences (NOK 73.2B) are the top three of the 24 biotech companies ranked by cash on hand as of 18 Nov 2026, 22:14 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of NOK 8.1T as of 18 Nov 2026, 22:14 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.